NCT06662110View on ClinicalTrials.gov

IMmune Proteomics to Predict NeoAdjuvant Chemotherapy and ImmunoTherapy Response in Gastric Cancer

RecruitingOBSERVATIONAL
Enrollment

206

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2029

Conditions
Gastric Cancer, Gastroesophageal Junction Cancer
Interventions
DIAGNOSTIC_TEST

PSRscore

PSRscore calculated based on baseline serum immune proteomics

Trial Locations (1)

200032

RECRUITING

Zhongshan Hospital, Fudan University, Xuhui District

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER